title: Cyclosporine improves results in HLA-identical sibling renal transplants.
authors.affiliation: Vanderbilt University Medical Center, Nashville, TN 37232-4750.
authors.forename: D
authors.initials: D
authors.lastname: Van Buren
authors.forename: R
authors.initials: R
authors.lastname: MacDonell
authors.forename: H K
authors.initials: HK
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Richie
authors.forename: C
authors.initials: C
authors.lastname: Ynares
authors.forename: J H
authors.initials: JH
authors.lastname: Helderman
authors.forename: W
authors.initials: W
authors.lastname: Green
authors.forename: D
authors.initials: D
authors.lastname: Crowe
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D015331:Cohort Studies; D016572:Cyclosporine / Q000627:therapeutic use*; D004200:Diseases in Twins; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate; D013997:Time Factors; D014430:Twins, Monozygotic
chemical_list: D000961:Antilymphocyte Serum; D006680:HLA Antigens; D016572:Cyclosporine